Insider Stock Trading History of Powell Andrew Kenneth William


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Powell Andrew Kenneth William since year 2005. The trader's CIK number is 1304113. At the time of this reporting, Powell Andrew Kenneth William is the SVP, General Counsel & Crp Sec of Medivation, Inc. . (stock ticker symbol MDVN). See this page for all insider trading activities at Medivation, Inc. .

Note that in the past Powell Andrew Kenneth William also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Powell Andrew Kenneth William since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-06-06 MDVN Medivation, Inc. Sale 2,578 60.42 155,762
2014-09-02 ITMN Intermune Inc Sale 7,500 73.47 551,032
2014-09-02 ITMN Intermune Inc Option Ex 7,500 15.00 112,500
2014-05-29 ITMN Intermune Inc Sale 500 39.56 19,780
2014-05-30 ITMN Intermune Inc Sale 500 39.32 19,662
2011-07-15 CRTX Critical Therapeutics Inc Sale 2,000 8.63 17,260
2011-04-04 CRTX Critical Therapeutics Inc Sale 2,000 6.53 13,060
2011-01-07 CRTX Critical Therapeutics Inc Sale 2,000 5.73 11,460
2010-11-01 CRTX Critical Therapeutics Inc Sale 7,900 6.28 49,612
2007-11-28 CGPI Collagenex Pharmaceuticals Inc Buy 200 7.30 1,460
2007-11-16 CGPI Collagenex Pharmaceuticals Inc Buy 400 8.01 3,204
2007-11-08 CGPI Collagenex Pharmaceuticals Inc Buy 450 8.47 3,811
2007-05-22 CGPI Collagenex Pharmaceuticals Inc Buy 200 10.48 2,096
2005-06-13 CGPI Collagenex Pharmaceuticals Inc Buy 1,800 4.86 8,757

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Powell Andrew Kenneth William (SVP, General Counsel & Crp Sec of Medivation, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.